TEVA 2050 TEVA 2050 (Tolterodine Tartrate Extended-Release 2 mg)
Pill with imprint TEVA 2050 TEVA 2050 is Green, Capsule-shape and has been identified as Tolterodine Tartrate Extended-Release 2 mg. It is supplied by Teva Pharmaceuticals USA Inc..
Tolterodine is used in the treatment of urinary frequency; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Tolterodine 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 2050 TEVA 2050
Tolterodine Tartrate Extended-Release
- Imprint
- TEVA 2050 TEVA 2050
- Strength
- 2 mg
- Color
- Green
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Urinary antispasmodics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC)
- 00093-2050
More about tolterodine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 64 Reviews
- Drug class: urinary antispasmodics
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.